angiotensin ii has been researched along with Rheumatoid Arthritis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Aal, SA; Al Khabbaz, HJ; Arab, HH; Arafa, EA; Ashour, AM; El-Sheikh, AAK; Kabel, AM; Mahmoud, AM | 1 |
| Abo-Saif, AA; El-Sayed El-Daly, M; Moustafa Ahmed, Y; Shehata Messiha, BA | 1 |
| Wang, C; Wang, X; Wang, Y; Zhang, H; Zhang, Y; Zhao, Z | 1 |
| Abreu, MAD; de Oliveira, TA; Moreira, FRC; Ramos, NE; Simões E Silva, AC | 1 |
| Chang, Y; Wei, W | 1 |
| Dagenais, NJ; Jamali, F | 1 |
| Albertazzi, L; Boiardi, L; Casali, B; Pattacini, L; Pipitone, N; Salvarani, C | 1 |
| Blake, DR; Knock, GA; Polak, JM; Suzuki, T; Walsh, DA; Wharton, J | 1 |
| Abramenko, TV; Alekperov, RT; Balabanova, RM; Garats, EV; Kiselev, IP; Kost, OA; Miagkova, MA; Nikol'skaia, II; Stanislav, ML | 1 |
3 review(s) available for angiotensin ii and Rheumatoid Arthritis
| Article | Year |
|---|---|
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Osteoarthritis; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Treatment Outcome | 2021 |
Angiotensin II in inflammation, immunity and rheumatoid arthritis.
Topics: Angiotensin II; Animals; Arthritis, Rheumatoid; Humans; Inflammation; Lupus Erythematosus, Systemic; Multiple Sclerosis | 2015 |
Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Clinical Trials as Topic; Cytokines; Drug Therapy, Combination; Humans; Inflammation Mediators; T-Lymphocytes, Helper-Inducer | 2005 |
6 other study(ies) available for angiotensin ii and Rheumatoid Arthritis
| Article | Year |
|---|---|
Targeting inflammation and redox perturbations by lisinopril mitigates Freund's adjuvant-induced arthritis in rats: role of JAK-2/STAT-3/RANKL axis, MMPs, and VEGF.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Freund's Adjuvant; Inflammation; Interleukin-17; Interleukin-6; Lipid Peroxides; Lisinopril; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Rats; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2022 |
Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.
Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Aorta; Arthritis, Rheumatoid; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Glucosides; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinases; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WF; Receptors, Purinergic P2Y12; Selective Estrogen Receptor Modulators; Sodium-Glucose Transporter 2 Inhibitors; Tamoxifen; Ticagrelor; Vascular Cell Adhesion Molecule-1; Vasodilation | 2019 |
Angiotensin II upregulates RANKL/NFATC1 expression in synovial cells from patients with rheumatoid arthritis through the ERK1/2 and JNK pathways.
Topics: Aged; Angiotensin II; Arthritis, Rheumatoid; Female; Gene Expression; Humans; Male; MAP Kinase Signaling System; Middle Aged; NFATC Transcription Factors; RANK Ligand; Receptor, Angiotensin, Type 1; Synovial Membrane; Up-Regulation | 2021 |
Angiotensin II protects fibroblast-like synoviocytes from apoptosis via the AT1-NF-kappaB pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Arthritis, Rheumatoid; Caspase 3; Cells, Cultured; Enzyme Activation; Fibroblasts; Humans; Losartan; NF-kappa B; Osteoarthritis, Hip; Receptor, Angiotensin, Type 1; Signal Transduction; Synovial Membrane | 2007 |
AT1 receptor characteristics of angiotensin analogue binding in human synovium.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Arthritis, Rheumatoid; Autoradiography; Biphenyl Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Imidazoles; Immunohistochemistry; In Vitro Techniques; Iodine Radioisotopes; Ligands; Losartan; Male; Middle Aged; Osteoarthritis; Pyridines; Receptors, Angiotensin; Synovial Fluid; Tetrazoles | 1994 |
[Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue].
Topics: Angiotensin II; Arthritis, Rheumatoid; Autoantibodies; Blood Donors; Bradykinin; Humans; Immunoenzyme Techniques; Immunoglobulin M; Lupus Erythematosus, Systemic; Peptidyl-Dipeptidase A; Scleroderma, Systemic; Spectrometry, Fluorescence; Vasopressins | 2001 |